Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Tonix Pharmaceuticals Announces Research Collaboration With Columbia University To Study Recombinant Trefoil Factor 2 Based Therapy For Gastric And Colorectal Cancers

TNX-1700 is Under Development as Monotherapy and in Combination with Anti-PD1 Checkpoint Inhibitor Therapy in Animal Models of Two Challenging Cancers   In Mouse Models, rTFF2 Detoxifies the Tumor Microenvironment,TNX-1700 is Under Development as Monotherapy and in Combination with Anti-PD1 Checkpoint Inhibitor Therapy in Animal Models of Two Challenging Cancers

TNXP